opc 12759 has been researched along with naproxen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Carvalhaes, A; De Nucci, G; Gagliano-Jucá, T; Magalhães, AF; Moreno, RA; Napolitano, M; Trevisan, MS; Wallace, JL; Zaminelli, T | 1 |
1 trial(s) available for opc 12759 and naproxen
| Article | Year |
|---|---|
Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial.
Topics: Adolescent; Adult; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Double-Blind Method; Female; Gastric Mucosa; Gastrointestinal Agents; Humans; Male; Middle Aged; Naproxen; Quinolones; Stomach Diseases; Young Adult | 2016 |
1 other study(ies) available for opc 12759 and naproxen
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |